Krsnaa Diagnostics Ltd will acquire a 23.53% stake in Apulki Healthcare Pvt Ltd, focusing on oncology and cardiology services, through a cash consideration within 3 months. The acquisition allows Krsnaa to operate and maintain diagnostic services at Apulkis hospitals.